Are Q1 ETF toppers healthy enough for further run in Q2?


U.S. equities were in fine fettle in the first quarter of 2017 barring some jitters in March. The S&P 500-based ETF SPY, Dow Jones-based ETF DIA and Nasdaq 100-based QQQ added in the range of 4.5% to 6%. In particular, the S&P 500 logged its best quarterly gain since 2015 and the Nasdaq experienced its best quarter since 2013.

Trump trade was mainly responsible for such impressive equity movements though uncertainty surmounted lately over the extension of the rally. Some of Trump’s pro-growth promises are likely to face lack of political support.

Development on the global front looked up even more in Q1 with all-world ETF iShares MSCI ACWI ACWI adding 6.9% so far this year (as of April 3, 2017), emerging market ETF iShares MSCI Emerging Markets EEM jumping 13.1% and Europe-oriented fund Vanguard FTSE Europe ETF VGK advancing 7.1%.

In such a scenario, it is wise to go for a health check-up of some top-performing ETFs of Q1 on World Health Day and find out if these are still sturdy enough for further run.

Zacks Investment Research

Zacks Investment Research

Zacks Investment Research is characterized by a team of experts who are passionate about your investing success and is focused on sharing the same reliable investment research they would want for themselves.

You May Also Like